000 01369 a2200397 4500
005 20250513184523.0
264 0 _c19990630
008 199906s 0 0 eng d
022 _a0008-543X
040 _aNLM
_beng
_cNLM
100 1 _aKahán, Z
245 0 0 _aComplete regression of MX-1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone-releasing hormone, AN-207.
_h[electronic resource]
260 _bCancer
_cJun 1999
300 _a2608-15 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aBreast Neoplasms
_xchemistry
650 0 4 _aDoxorubicin
_xanalogs & derivatives
650 0 4 _aFemale
650 0 4 _aGonadotropin-Releasing Hormone
_xanalogs & derivatives
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aNeoplasm Transplantation
650 0 4 _aRNA, Messenger
_xbiosynthesis
650 0 4 _aReceptors, LHRH
_xdrug effects
650 0 4 _aTransplantation, Heterologous
700 1 _aNagy, A
700 1 _aSchally, A V
700 1 _aHalmos, G
700 1 _aArencibia, J M
700 1 _aGroot, K
773 0 _tCancer
_gvol. 85
_gno. 12
_gp. 2608-15
999 _c10333574
_d10333574